Perioperative Opioid-sparing Effect of Retrosuperior Costotransverse Ligament Block Versus Erector Spinae Block in Laparoscopic Cholecystectomy

NCT ID: NCT07276646

Last Updated: 2025-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-10

Study Completion Date

2026-07-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to compare the analgesic effect of retro superior costotransverse ligament space block vs erector spinae plane block to Achieve high-quality perioperative opioid-sparing effect and postoperative analgesia after laparoscopic cholecystectomy with optimum hemodynamic stability and high patient and surgeon satisfaction

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to compare between retro superior costotransverse ligament space block vs erector spinae plane block

* To compare the analgesic outcomes (time to first analgesic request, total amount of analgesic consumption and pain scores by NRS)
* To assess the block performance time required to perform each technique .
* To compare intraoperative parameters (hemodynamics and intraoperative fentanyl consumption)
* To assess patient, surgeon satisfaction and complications of the block.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Perioperative Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Achievement of high-quality perioperative opioid-sparing effect and postoperative analgesia for laparoscopic cholecystectomy with optimum hemodynamic stability and high patient and surgeon satisfaction by comparing retrosuperior costotransverse ligament block and erector spinae block in laparoscopic cholecystectomy
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
anesthesiologist not sharing in the study will assess outcomes

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Retrosuperior costotransverse ligament block group

The patient will receive retrosuperior costotransverse ligament block

Group Type ACTIVE_COMPARATOR

Retrosuperior costotransverse ligament block group

Intervention Type PROCEDURE

The patient will receive retrosuperior costotransverse ligament block

Erector spinae block group

The patient will receive erector spinae block.

Group Type ACTIVE_COMPARATOR

Erector spinae block group

Intervention Type PROCEDURE

The patient will receive erector spinae block.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Retrosuperior costotransverse ligament block group

The patient will receive retrosuperior costotransverse ligament block

Intervention Type PROCEDURE

Erector spinae block group

The patient will receive erector spinae block.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. patient acceptance
2. Age: 21-64 years old.
3. Sex: both sexes.
4. Physical status: ASA I \& II.
5. Body mass index (BMI): 18.5 - 30 kg/m2.
6. Type of operations: elective laparoscopic cholecystectomy.
7. Duration of surgery not more than 2 hours.

Exclusion Criteria

1. Known hypersensitivity to lidocaine or bupivacaine.
2. Patients with respiratory insufficiency.
3. Coagulation disorders or taking drugs affect surgical hemostasis.

7\. Patients with pre-existing neurological deficits. 8. Uncooperative patient or with altered mental status. 9. Patient with advanced cardiovascular or respiratory diseases
Minimum Eligible Age

21 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zagazig University

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dina Abdelhameed Elsadek Salem

Associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of human medicine, Zagazig university, Zagazig

Zagazig, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dina Salem, MD

Role: CONTACT

01099333513 ext. 002

Marwa Medhat, MD

Role: CONTACT

01002828937 ext. 002

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dina Salem, MD

Role: primary

01099333513 ext. 002

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1783

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Comparison of ESP Block and STAP Plane Block
NCT06663449 NOT_YET_RECRUITING NA